REFERENCES
- Cancer incidence in Sweden 1996. Stockholm: Epide-miologiskt centrum, Socialstyrelsen, 1998.
- Schuessler WW, Schulam PG, Clayman RV, Kavoussi LR. Laparoscopic radical prostatectomy: Initial short-term experience. Urology 1997; 50: 854–7.
- Patientregistret avseende operationer i Sverige 1994-1997. Stockholm: Epidemiologiskt centrum, Socialsty-relsen, 1998.
- Mostofi FK, Sesterhenn IA, Sobin LH. In: Histologic typing of prostate tumors, ed. Geneva: World Health Organization; 1980, pp. 17–21.
- Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma combining histological grad-ing and clinical staging. (VACURG) J Urol 1974; 11: 58–64
- Lilja H, Christensson A, Dahlen U, et al. Prostate specific antigen in serum occurs predominantly in complex with alfal-antichymotrypsin. Clin Chem 1991; 37:1618–25.
- Hudson MA, Bahnson RR, Catalona WJ. Clinical use of prostatic specific antigen in patients with prostate cancer. J Urol 1989; 142: 1011–17.
- Peto R, Pike C, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1–38.
- Pound CR, Partin AW, Epstein JL, Walsh PC. Prostate specific antigen after anatomic radical retropubic pros-tatectomy: patterns of recurrence and cancer control. Urol Clin N Am 1997: 395–406.
- Rioja Sanz LA, Liedana Torres JM, Ronca-les Badal A, Gil Sanz MJ, Villanueva Benedict° A, Rodriguez Vela L, et al. Analysis of a series of radical prostatectomies. Actas Urol Esp 1997; 21: 809–16.
- Austenfeld MS, Davis BE. New concepts in the treatment of stage D1 adenocarcinoma of the prostate. Review. Urol Clin North Am 1990; 17: 867–84.
- Dhoti M, Wheeler TM, Kattan MW, Goto Y, Scardino PT. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 1995; 154: 1818–24.
- Wieder JA, Soloway MS. Incidence, aetiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol 1998; 160: 299–315.
- Paulson DF, Stone AR, Walther PJ, Tucker JA, Cox EB. Radical prostatectomy: anatomical predictors of success or failure. J Urol 1986; 136: 1041–3.
- Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic pros-tatectomy. Cancer 1993; 71: 3582.
- Catalona WJ, Smith DS. Five-year tumour recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994; 152: 1837–42.
- Partin AW, Lee BR, Carmichael M, Walsh PC, Epstein H. Radical prostatectomy for high grade disease: a reevaluation. J Urol 1994; 151: 1583–6.
- Sandblom G, Mattsson E, Nilsson J, Damber J-E, Johansson J-E, Lundgren R, et al. Prostate cancer registration in four Swedish regions 1996; differences in incidence, age structure and management. Scand J Urol Nephrol 1999; 33: 306–11.
- Lange P, Narayan P. Understaging and undergrading of prostate cancer. Urology 1983; 21: 113–18.
- Norberg M, Egevad L, Holmberg L, Sparén P, Norlén BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997; 50: 562–6.